Abstract:Abstract Background Since the global pandemic of coronavirus disease (COVID-19), some studies have reported on the emergence of opportunistic nosocomial pathogens associated with co-infection on the outcome of COVID-19 patients. The aim of this study was to describe the increase of six unusual species of Non-fermentative Gram-negative bacilli (NF-GNB) clinical isolates recovered from inpatients in several Brazilian hospitals comparing pre-Covid-19 (January 2018 to December 2019) period vs Covid-19 (January 2020 to December 2021) period. Methods This study design was a retrospective, observational analysis based on microbiological data of emergent NF-GNB isolates, detected in several Brazilian tertiary hospitals. The bacterial identification was performed by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF/MS) and the susceptibility of antibiotics was determined using disk diffusion method. Results During the 48 months period, a total of 1665 (2018; 349), (2019; 351), (2020; 485), (2021; 480) emergent NF-GNB isolated from blood (n = 744), respiratory tract (n = 239), skin and soft tissue (n = 264); urine (n = 119), catheter (n = 101), fluid and secretions (n = 113), Cerebrospinal fluid (n = 12) and others (n = 73) were analyzed. The frequency of NF-BGN according to species level identification was Stenotrophomonas maltophilia (1040; 62.5%), Burkholderia cepacea complex (457; 27.4%), Elizabethkingia meningoseptica (64; 3.8%), Elizabethkingia miricola (31; 1.8%), Ochrobactrum anthropi (69; 4.1%) and Ochrobactrum intermedium (4; 0.2%). The prevalence of these NF-BGN detected in pre-Covid-19 period (2018–2019) and Covid-19 period (2020–2021) were 42% and 58%, respectively. The incidence of Stenotrophomonas maltophilia, Burkholderia cepacea complex, Elizabethkingia spp. and Ochrobactrum spp. infection was (47.7% and 52.3%), (42.9% and 57.1%), (43.2% and 56.8%) and (50.7% and 49.3%) among female and man patients, respectively. For Stenotrophomonas maltophilia, Burkholderia cepacea complex and Ochrobactrum spp. the main age range was over 60 years (44.5%, 44.9% and 42.5%) while for Elizabethkingia spp. the main age range was 0–10 years of age with 42.5% of cases in the pre-COVID-19 period and over 60 years old with 43.9% in the COVID-19 period. Compared the two periods (2018–2019 vs 2020–2021) for Stenotrophomonas maltophilia the resistance rate to levofloxacin and sulfamethoxazole-trimethoprim was (3.9% vs 4.6%) and (4% vs 4.2%), respectively. Conclusion Our data point to a scenario wherein the presence of opportunistic pathogens may have been intensified by the covid-19 pandemic. Further studies should be carried out to clarify these findings.

Trends in hospital acquired New Delhi metallo-beta-lactamase-producing Enterobacterales in Tuscany (Italy) from 2019 to 2021: impact of the COVID-19 pandemic

Increase of multidrug-resistant bacteria after the COVID-19 pandemic in a major teaching Hospital in Sicily (2018-2021)

Anatomy of an extensively drug-resistant Klebsiella pneumoniae outbreak in Tuscany, Italy

Reduction of Multidrug-Resistant (MDR) Bacterial Infections during the COVID-19 Pandemic: A Retrospective Study

Genomic surveillance of carbapenem-resistant Klebsiella pneumoniae reveals a prolonged outbreak of extensively drug-resistant ST147 NDM-1 during the COVID-19 pandemic in the Apulia region (Southern Italy)

Understanding the burden of antibiotic resistance: a decade of carbapenem-resistant Gram-negative bacterial infections in Italian intensive care units

Epidemiological and molecular study of Providencia rettgeri outbreak at a university hospital during the COVID-19 reference center

Trends in Antibiotic Resistance of Nosocomial and Community-Acquired Infections in Italy

Surveillance of Multidrug-Resistant Pathogens in Neonatal Intensive Care Units of Palermo, Italy, during SARS-CoV-2 Pandemic

Investigation of Healthcare-Acquired Infections and Antimicrobial Resistance in an Italian Hematology Department before and during the COVID-19 Pandemic

Molecular Characterization of Multidrug-Resistant and Hypervirulent New Delhi Metallo-Beta-Lactamase Klebsiella pneumoniae in Lazio, Italy: A Five-Year Retrospective Study

A-289 Emergence of Unusual Non-Fermentative Gram-Negative Bacilli Associated to COVID-19 Period at Brazilian Hospitals

The Impact of COVID-19 on Multidrug-Resistant Bacteria at a Slovenian Tertiary Medical Center

Multidrug-resistant organism bloodstream infection and hospital acquisition among inpatients in three tertiary Greek hospitals during the COVID-19 era

Increase of healthcare-onset Clostridioides difficile infection in adult population since SARS-CoV-2 pandemic: A retrospective cohort study in a tertiary care hospital from 2019 to 2022

Device-Associated Infections in COVID-19 Patients: Frequency of Resistant Bacteria, Predictors and Mortality in Medellín, Colombia

Incidence of bloodstream infections due to multidrug-resistant pathogens in ordinary wards and intensive care units before and during the COVID-19 pandemic: a real-life, retrospective observational study

National Multicenter Study on the Prevalence of Carbapenemase-Producing Enterobacteriaceae in the Post-COVID-19 Era in Argentina: The RECAPT-AR Study

Clinical Features and Outcomes of Infections Caused by Metallo-β-Lactamase-Producing Enterobacterales: A 3-Year Prospective Study From an Endemic Area

Epidemiology of bloodstream infections caused by extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae in Switzerland, 2015-2022: secular trends and association with the COVID-19 pandemic

First report of a blaNDM-producing extensively drug resistant Klebsiella pneumoniae ST437 in Italy